Personalized Medicine - Global Market Outlook (2016-2022)
According to Stratistics MRC, the Global Personalized Medicine Market accounted for $94.49 billion in 2015 and is expected to reach $178.78 million by 2022 growing at a CAGR of 9.5% from 2015 to 2022. Increased healthcare spending, growing incidence of cancer and rising adoption of next generation sequencing are few factors expected to fuel the market growth. Furthermore, government reimbursements for personalized medicine and regulatory scenario are the factors anticipated to propel the demand during the forecast period. However, complexity involved in usage of the drugs, huge development costs and inter-patient changeability of effects are some of the factors hindering the market.
North America commanded the market owing to technological advancements and increased R&D investments by various biotechnology companies in the region. However, the Asia-Pacific is expected to observe significant growth over the forecast period owing to the presence of a huge base of unmet market demand. Personalized medicines have major impact on SME’s and offer lucrative opportunities for these companies to expand their industrial boundaries across the world.
Some of the key players in the market are Siemens Healthcare Diagnostics Inc., Sanofi, Quest Diagnostics, Qiagen Inc., Pfizer Inc., Laboratory Corporation of America, Illumina Inc., GE Healthcare, Foundation Medicine Inc., CardioDx Inc., Bristol-Myers Squibb, Becton Dickinson & Co., Asuragen Inc., Amgen Inc., Agendia NV, Abbott and 3G Biotech.
End Users Covered:
North America commanded the market owing to technological advancements and increased R&D investments by various biotechnology companies in the region. However, the Asia-Pacific is expected to observe significant growth over the forecast period owing to the presence of a huge base of unmet market demand. Personalized medicines have major impact on SME’s and offer lucrative opportunities for these companies to expand their industrial boundaries across the world.
Some of the key players in the market are Siemens Healthcare Diagnostics Inc., Sanofi, Quest Diagnostics, Qiagen Inc., Pfizer Inc., Laboratory Corporation of America, Illumina Inc., GE Healthcare, Foundation Medicine Inc., CardioDx Inc., Bristol-Myers Squibb, Becton Dickinson & Co., Asuragen Inc., Amgen Inc., Agendia NV, Abbott and 3G Biotech.
End Users Covered:
- Academic Institutes and Research Laboratories
- Bio and health informatics companies
- Contract Research Organizations
- Hospitals
- Molecular Diagnostic Laboratories and Testing facilities
- Other End Users
- Venture capitalists
- Service providers
- Partners
- Health Informatics
- Companion Diagnostics
- Clinical Research
- Biomarker identification
- Infectious Diseases
- Hospital Acquired Infections
- HIV
- HCV
- HBV
- Coagulation Therapy
- Autoimmune Diseases
- Cardiovascular Diseases
- CNS Disorders
- Diabetes
- Blood Transfusion Safety
- Cancer Management
- Blood Markers
- Circulating Tumor Cells
- Tissue-based Tests
- Others
- Personalized Medicine Therapeutics
- Genomic Medicine
- Medical Devices
- Pharmaceutical
- Personalized Nutrition & Wellness
- Alternative Medicine
- Complementary Medicine
- Retail Nutrition
- Personalized Medical Care
- Diseases Management
- Healthcare Information Technology
- Telemedicine
- Personalized Medicine Diagnostics
- Direct-to-consumer Diagnostics
- Esoteric Lab Services
- Esoteric Lab Tests
- Genetic Testing
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Product Analysis
3.9 Emerging Markets
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL PERSONALIZED MEDICINE MARKET, BY END USER
5.1 Introduction
5.2 Academic Institutes and Research Laboratories
5.3 Bio and health informatics companies
5.4 Contract Research Organizations
5.5 Hospitals
5.6 Molecular Diagnostic Laboratories and Testing facilities
5.7 Other End Users
5.7.1 Venture capitalists
5.7.2 Service providers
5.7.3 Partners
6 GLOBAL PERSONALIZED MEDICINE MARKET, BY APPLICATION
6.1 Introduction
6.2 Health Informatics
6.3 Companion Diagnostics
6.4 Clinical Research
6.5 Biomarker identification
7 GLOBAL PERSONALIZED MEDICINE MARKET, BY THERAPEUTIC AREA
7.1 Introduction
7.2 Infectious Diseases
7.2.1 Hospital Acquired Infections
7.2.2 HIV
7.2.3 HCV
7.2.4 HBV
7.3 Coagulation Therapy
7.4 Autoimmune Diseases
7.5 Cardiovascular Diseases
7.6 CNS Disorders
7.7 Diabetes
7.8 Blood Transfusion Safety
7.9 Cancer Management
7.9.1 Blood Markers
7.9.2 Circulating Tumor Cells
7.9.3 Tissue-based Tests
7.10 Others
8 GLOBAL PERSONALIZED MEDICINE MARKET, BY PRODUCT
8.1 Introduction
8.2 Personalized Medicine Therapeutics
8.2.1 Genomic Medicine
8.2.2 Medical Devices
8.2.3 Pharmaceutical
8.3 Personalized Nutrition & Wellness
8.3.1 Alternative Medicine
8.3.2 Complementary Medicine
8.3.3 Retail Nutrition
8.4 Personalized Medical Care
8.4.1 Diseases Management
8.4.2 Healthcare Information Technology
8.4.3 Telemedicine
8.5 Personalized Medicine Diagnostics
8.5.1 Direct-to-consumer Diagnostics
8.5.2 Esoteric Lab Services
8.5.3 Esoteric Lab Tests
8.5.4 Genetic Testing
9 GLOBAL PERSONALIZED MEDICINE MARKET, BY GEOGRAPHY
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.9 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.9 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt
10 KEY DEVELOPMENTS
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 COMPANY PROFILING
11.1 Siemens Healthcare Diagnostics Inc.
11.2 Sanofi
11.3 Quest Diagnostics
11.4 Qiagen Inc.
11.5 Pfizer Inc.
11.6 Laboratory Corporation of America
11.7 Illumina Inc.
11.11 GE Healthcare
11.9 Foundation Medicine Inc.
11.10 CardioDx Inc.
11.11 Bristol-Myers Squibb
11.12 Becton Dickinson & Co.
11.13 Asuragen Inc
11.14 Amgen Inc.
11.15 Agendia NV
11.16 Abbott
11.17 3G Biotech
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Product Analysis
3.9 Emerging Markets
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL PERSONALIZED MEDICINE MARKET, BY END USER
5.1 Introduction
5.2 Academic Institutes and Research Laboratories
5.3 Bio and health informatics companies
5.4 Contract Research Organizations
5.5 Hospitals
5.6 Molecular Diagnostic Laboratories and Testing facilities
5.7 Other End Users
5.7.1 Venture capitalists
5.7.2 Service providers
5.7.3 Partners
6 GLOBAL PERSONALIZED MEDICINE MARKET, BY APPLICATION
6.1 Introduction
6.2 Health Informatics
6.3 Companion Diagnostics
6.4 Clinical Research
6.5 Biomarker identification
7 GLOBAL PERSONALIZED MEDICINE MARKET, BY THERAPEUTIC AREA
7.1 Introduction
7.2 Infectious Diseases
7.2.1 Hospital Acquired Infections
7.2.2 HIV
7.2.3 HCV
7.2.4 HBV
7.3 Coagulation Therapy
7.4 Autoimmune Diseases
7.5 Cardiovascular Diseases
7.6 CNS Disorders
7.7 Diabetes
7.8 Blood Transfusion Safety
7.9 Cancer Management
7.9.1 Blood Markers
7.9.2 Circulating Tumor Cells
7.9.3 Tissue-based Tests
7.10 Others
8 GLOBAL PERSONALIZED MEDICINE MARKET, BY PRODUCT
8.1 Introduction
8.2 Personalized Medicine Therapeutics
8.2.1 Genomic Medicine
8.2.2 Medical Devices
8.2.3 Pharmaceutical
8.3 Personalized Nutrition & Wellness
8.3.1 Alternative Medicine
8.3.2 Complementary Medicine
8.3.3 Retail Nutrition
8.4 Personalized Medical Care
8.4.1 Diseases Management
8.4.2 Healthcare Information Technology
8.4.3 Telemedicine
8.5 Personalized Medicine Diagnostics
8.5.1 Direct-to-consumer Diagnostics
8.5.2 Esoteric Lab Services
8.5.3 Esoteric Lab Tests
8.5.4 Genetic Testing
9 GLOBAL PERSONALIZED MEDICINE MARKET, BY GEOGRAPHY
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.9 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.9 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt
10 KEY DEVELOPMENTS
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 COMPANY PROFILING
11.1 Siemens Healthcare Diagnostics Inc.
11.2 Sanofi
11.3 Quest Diagnostics
11.4 Qiagen Inc.
11.5 Pfizer Inc.
11.6 Laboratory Corporation of America
11.7 Illumina Inc.
11.11 GE Healthcare
11.9 Foundation Medicine Inc.
11.10 CardioDx Inc.
11.11 Bristol-Myers Squibb
11.12 Becton Dickinson & Co.
11.13 Asuragen Inc
11.14 Amgen Inc.
11.15 Agendia NV
11.16 Abbott
11.17 3G Biotech
LIST OF TABLES
Table 1 Global Personalized Medicine Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Personalized Medicine Market Outlook, By Academic Institutes and Research Laboratories (2013-2022) ($MN)
Table 3 Global Personalized Medicine Market Outlook, By Bio and health informatics companies (2013-2022) ($MN)
Table 4 Global Personalized Medicine Market Outlook, By Contract Research Organizations (2013-2022) ($MN)
Table 5 Global Personalized Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
Table 6 Global Personalized Medicine Market Outlook, By Molecular Diagnostic Laboratories and Testing facilities (2013-2022) ($MN)
Table 7 Global Personalized Medicine Market Outlook, By Other End Users (2013-2022) ($MN)
Table 8 Global Personalized Medicine Market Outlook, By Venture capitalists (2013-2022) ($MN)
Table 9 Global Personalized Medicine Market Outlook, By Service providers (2013-2022) ($MN)
Table 10 Global Personalized Medicine Market Outlook, By Partners (2013-2022) ($MN)
Table 11 Global Personalized Medicine Market Outlook, By Application (2013-2022) ($MN)
Table 12 Global Personalized Medicine Market Outlook, By Health Informatics (2013-2022) ($MN)
Table 13 Global Personalized Medicine Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Table 14 Global Personalized Medicine Market Outlook, By Clinical Research (2013-2022) ($MN)
Table 15 Global Personalized Medicine Market Outlook, By Biomarker identification (2013-2022) ($MN)
Table 16 Global Personalized Medicine Market Outlook, By Therapeutic area (2013-2022) ($MN)
Table 17 Global Personalized Medicine Market Outlook, By Infectious Diseases (2013-2022) ($MN)
Table 18 Global Personalized Medicine Market Outlook, By Hospital Acquired Infections (2013-2022) ($MN)
Table 19 Global Personalized Medicine Market Outlook, By HIV (2013-2022) ($MN)
Table 20 Global Personalized Medicine Market Outlook, By HCV (2013-2022) ($MN)
Table 21 Global Personalized Medicine Market Outlook, By HBV (2013-2022) ($MN)
Table 22 Global Personalized Medicine Market Outlook, By Coagulation Therapy (2013-2022) ($MN)
Table 23 Global Personalized Medicine Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
Table 24 Global Personalized Medicine Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)
Table 25 Global Personalized Medicine Market Outlook, By CNS Disorders (2013-2022) ($MN)
Table 26 Global Personalized Medicine Market Outlook, By Diabetes (2013-2022) ($MN)
Table 27 Global Personalized Medicine Market Outlook, By Blood Transfusion Safety (2013-2022) ($MN)
Table 28 Global Personalized Medicine Market Outlook, By Cancer Management (2013-2022) ($MN)
Table 29 Global Personalized Medicine Market Outlook, By Blood Markers (2013-2022) ($MN)
Table 30 Global Personalized Medicine Market Outlook, By Circulating Tumor Cells (2013-2022) ($MN)
Table 31 Global Personalized Medicine Market Outlook, By Tissue-based Tests (2013-2022) ($MN)
Table 32 Global Personalized Medicine Market Outlook, By Others (2013-2022) ($MN)
Table 33 Global Personalized Medicine Market Outlook, By Product (2013-2022) ($MN)
Table 34 Global Personalized Medicine Market Outlook, By Personalized Medicine Therapeutics (2013-2022) ($MN)
Table 35 Global Personalized Medicine Market Outlook, By Genomic Medicine (2013-2022) ($MN)
Table 36 Global Personalized Medicine Market Outlook, By Medical Devices (2013-2022) ($MN)
Table 37 Global Personalized Medicine Market Outlook, By Pharmaceutical (2013-2022) ($MN)
Table 38 Global Personalized Medicine Market Outlook, By Personalized Nutrition & Wellness (2013-2022) ($MN)
Table 39 Global Personalized Medicine Market Outlook, By Alternative Medicine (2013-2022) ($MN)
Table 40 Global Personalized Medicine Market Outlook, By Complementary Medicine (2013-2022) ($MN)
Table 41 Global Personalized Medicine Market Outlook, By Retail Nutrition (2013-2022) ($MN)
Table 42 Global Personalized Medicine Market Outlook, By Personalized Medical Care (2013-2022) ($MN)
Table 43 Global Personalized Medicine Market Outlook, By Diseases Management (2013-2022) ($MN)
Table 44 Global Personalized Medicine Market Outlook, By Healthcare Information Technology (2013-2022) ($MN)
Table 45 Global Personalized Medicine Market Outlook, By Telemedicine (2013-2022) ($MN)
Table 46 Global Personalized Medicine Market Outlook, By Personalized Medicine Diagnostics (2013-2022) ($MN)
Table 47 Global Personalized Medicine Market Outlook, By Direct-to-consumer Diagnostics (2013-2022) ($MN)
Table 48 Global Personalized Medicine Market Outlook, By Esoteric Lab Services (2013-2022) ($MN)
Table 49 Global Personalized Medicine Market Outlook, By Esoteric Lab Tests (2013-2022) ($MN)
Table 50 Global Personalized Medicine Market Outlook, By Genetic Testing (2013-2022) ($MN)
Table 51 North America Personalized Medicine Market Outlook, By Country (2013-2022) ($MN)
Table 52 North America Personalized Medicine Market Outlook, By Academic Institutes and Research Laboratories (2013-2022) ($MN)
Table 53 North America Personalized Medicine Market Outlook, By Bio and health informatics companies (2013-2022) ($MN)
Table 54 North America Personalized Medicine Market Outlook, By Contract Research Organizations (2013-2022) ($MN)
Table 55 North America Personalized Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
Table 56 North America Personalized Medicine Market Outlook, By Molecular Diagnostic Laboratories and Testing facilities (2013-2022) ($MN)
Table 57 North America Personalized Medicine Market Outlook, By Other End Users (2013-2022) ($MN)
Table 58 North America Personalized Medicine Market Outlook, By Venture capitalists (2013-2022) ($MN)
Table 59 North America Personalized Medicine Market Outlook, By Service providers (2013-2022) ($MN)
Table 60 North America Personalized Medicine Market Outlook, By Partners (2013-2022) ($MN)
Table 61 North America Personalized Medicine Market Outlook, By Application (2013-2022) ($MN)
Table 62 North America Personalized Medicine Market Outlook, By Health Informatics (2013-2022) ($MN)
Table 63 North America Personalized Medicine Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Table 64 North America Personalized Medicine Market Outlook, By Clinical Research (2013-2022) ($MN)
Table 65 North America Personalized Medicine Market Outlook, By Biomarker identification (2013-2022) ($MN)
Table 66 North America Personalized Medicine Market Outlook, By Therapeutic area (2013-2022) ($MN)
Table 67 North America Personalized Medicine Market Outlook, By Infectious Diseases (2013-2022) ($MN)
Table 68 North America Personalized Medicine Market Outlook, By Hospital Acquired Infections (2013-2022) ($MN)
Table 69 North America Personalized Medicine Market Outlook, By HIV (2013-2022) ($MN)
Table 70 North America Personalized Medicine Market Outlook, By HCV (2013-2022) ($MN)
Table 71 North America Personalized Medicine Market Outlook, By HBV (2013-2022) ($MN)
Table 72 North America Personalized Medicine Market Outlook, By Coagulation Therapy (2013-2022) ($MN)
Table 73 North America Personalized Medicine Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
Table 74 North America Personalized Medicine Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)
Table 75 North America Personalized Medicine Market Outlook, By CNS Disorders (2013-2022) ($MN)
Table 76 North America Personalized Medicine Market Outlook, By Diabetes (2013-2022) ($MN)
Table 77 North America Personalized Medicine Market Outlook, By Blood Transfusion Safety (2013-2022) ($MN)
Table 78 North America Personalized Medicine Market Outlook, By Cancer Management (2013-2022) ($MN)
Table 79 North America Personalized Medicine Market Outlook, By Blood Markers (2013-2022) ($MN)
Table 80 North America Personalized Medicine Market Outlook, By Circulating Tumor Cells (2013-2022) ($MN)
Table 81 North America Personalized Medicine Market Outlook, By Tissue-based Tests (2013-2022) ($MN)
Table 82 North America Personalized Medicine Market Outlook, By Others (2013-2022) ($MN)
Table 83 North America Personalized Medicine Market Outlook, By Product (2013-2022) ($MN)
Table 84 North America Personalized Medicine Market Outlook, By Personalized Medicine Therapeutics (2013-2022) ($MN)
Table 85 North America Personalized Medicine Market Outlook, By Genomic Medicine (2013-2022) ($MN)
Table 86 North America Personalized Medicine Market Outlook, By Medical Devices (2013-2022) ($MN)
Table 87 North America Personalized Medicine Market Outlook, By Pharmaceutical (2013-2022) ($MN)
Table 88 North America Personalized Medicine Market Outlook, By Personalized Nutrition & Wellness (2013-2022) ($MN)
Table 89 North America Personalized Medicine Market Outlook, By Alternative Medicine (2013-2022) ($MN)
Table 90 North America Personalized Medicine Market Outlook, By Complementary Medicine (2013-2022) ($MN)
Table 91 North America Personalized Medicine Market Outlook, By Retail Nutrition (2013-2022) ($MN)
Table 92 North America Personalized Medicine Market Outlook, By Personalized Medical Care (2013-2022) ($MN)
Table 93 North America Personalized Medicine Market Outlook, By Diseases Management (2013-2022) ($MN)
Table 94 North America Personalized Medicine Market Outlook, By Healthcare Information Technology (2013-2022) ($MN)
Table 95 North America Personalized Medicine Market Outlook, By Telemedicine (2013-2022) ($MN)
Table 96 North America Personalized Medicine Market Outlook, By Personalized Medicine Diagnostics (2013-2022) ($MN)
Table 97 North America Personalized Medicine Market Outlook, By Direct-to-consumer Diagnostics (2013-2022) ($MN)
Table 98 North America Personalized Medicine Market Outlook, By Esoteric Lab Services (2013-2022) ($MN)
Table 99 North America Personalized Medicine Market Outlook, By Esoteric Lab Tests (2013-2022) ($MN)
Table 100 North America Personalized Medicine Market Outlook, By Genetic Testing (2013-2022) ($MN)
Table 101 Europe Personalized Medicine Market Outlook, By Country (2013-2022) ($MN)
Table 102 Europe Personalized Medicine Market Outlook, By Academic Institutes and Research Laboratories (2013-2022) ($MN)
Table 103 Europe Personalized Medicine Market Outlook, By Bio and health informatics companies (2013-2022) ($MN)
Table 104 Europe Personalized Medicine Market Outlook, By Contract Research Organizations (2013-2022) ($MN)
Table 105 Europe Personalized Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
Table 106 Europe Personalized Medicine Market Outlook, By Molecular Diagnostic Laboratories and Testing facilities (2013-2022) ($MN)
Table 107 Europe Personalized Medicine Market Outlook, By Other End Users (2013-2022) ($MN)
Table 108 Europe Personalized Medicine Market Outlook, By Venture capitalists (2013-2022) ($MN)
Table 109 Europe Personalized Medicine Market Outlook, By Service providers (2013-2022) ($MN)
Table 110 Europe Personalized Medicine Market Outlook, By Partners (2013-2022) ($MN)
Table 111 Europe Personalized Medicine Market Outlook, By Application (2013-2022) ($MN)
Table 112 Europe Personalized Medicine Market Outlook, By Health Informatics (2013-2022) ($MN)
Table 113 Europe Personalized Medicine Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Table 114 Europe Personalized Medicine Market Outlook, By Clinical Research (2013-2022) ($MN)
Table 115 Europe Personalized Medicine Market Outlook, By Biomarker identification (2013-2022) ($MN)
Table 116 Europe Personalized Medicine Market Outlook, By Therapeutic area (2013-2022) ($MN)
Table 117 Europe Personalized Medicine Market Outlook, By Infectious Diseases (2013-2022) ($MN)
Table 118 Europe Personalized Medicine Market Outlook, By Hospital Acquired Infections (2013-2022) ($MN)
Table 119 Europe Personalized Medicine Market Outlook, By HIV (2013-2022) ($MN)
Table 120 Europe Personalized Medicine Market Outlook, By HCV (2013-2022) ($MN)
Table 121 Europe Personalized Medicine Market Outlook, By HBV (2013-2022) ($MN)
Table 122 Europe Personalized Medicine Market Outlook, By Coagulation Therapy (2013-2022) ($MN)
Table 123 Europe Personalized Medicine Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
Table 124 Europe Personalized Medicine Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)
Table 125 Europe Personalized Medicine Market Outlook, By CNS Disorders (2013-2022) ($MN)
Table 126 Europe Personalized Medicine Market Outlook, By Diabetes (2013-2022) ($MN)
Table 127 Europe Personalized Medicine Market Outlook, By Blood Transfusion Safety (2013-2022) ($MN)
Table 128 Europe Personalized Medicine Market Outlook, By Cancer Management (2013-2022) ($MN)
Table 129 Europe Personalized Medicine Market Outlook, By Blood Markers (2013-2022) ($MN)
Table 130 Europe Personalized Medicine Market Outlook, By Circulating Tumor Cells (2013-2022) ($MN)
Table 131 Europe Personalized Medicine Market Outlook, By Tissue-based Tests (2013-2022) ($MN)
Table 132 Europe Personalized Medicine Market Outlook, By Others (2013-2022) ($MN)
Table 133 Europe Personalized Medicine Market Outlook, By Product (2013-2022) ($MN)
Table 134 Europe Personalized Medicine Market Outlook, By Personalized Medicine Therapeutics (2013-2022) ($MN)
Table 135 Europe Personalized Medicine Market Outlook, By Genomic Medicine (2013-2022) ($MN)
Table 136 Europe Personalized Medicine Market Outlook, By Medical Devices (2013-2022) ($MN)
Table 137 Europe Personalized Medicine Market Outlook, By Pharmaceutical (2013-2022) ($MN)
Table 138 Europe Personalized Medicine Market Outlook, By Personalized Nutrition & Wellness (2013-2022) ($MN)
Table 139 Europe Personalized Medicine Market Outlook, By Alternative Medicine (2013-2022) ($MN)
Table 140 Europe Personalized Medicine Market Outlook, By Complementary Medicine (2013-2022) ($MN)
Table 141 Europe Personalized Medicine Market Outlook, By Retail Nutrition (2013-2022) ($MN)
Table 142 Europe Personalized Medicine Market Outlook, By Personalized Medical Care (2013-2022) ($MN)
Table 143 Europe Personalized Medicine Market Outlook, By Diseases Management (2013-2022) ($MN)
Table 144 Europe Personalized Medicine Market Outlook, By Healthcare Information Technology (2013-2022) ($MN)
Table 145 Europe Personalized Medicine Market Outlook, By Telemedicine (2013-2022) ($MN)
Table 146 Europe Personalized Medicine Market Outlook, By Personalized Medicine Diagnostics (2013-2022) ($MN)
Table 147 Europe Personalized Medicine Market Outlook, By Direct-to-consumer Diagnostics (2013-2022) ($MN)
Table 148 Europe Personalized Medicine Market Outlook, By Esoteric Lab Services (2013-2022) ($MN)
Table 149 Europe Personalized Medicine Market Outlook, By Esoteric Lab Tests (2013-2022) ($MN)
Table 150 Europe Personalized Medicine Market Outlook, By Genetic Testing (2013-2022) ($MN)
Table 151 Asia Pacific Personalized Medicine Market Outlook, By Country (2013-2022) ($MN)
Table 152 Asia Pacific Personalized Medicine Market Outlook, By Academic Institutes and Research Laboratories (2013-2022) ($MN)
Table 153 Asia Pacific Personalized Medicine Market Outlook, By Bio and health informatics companies (2013-2022) ($MN)
Table 154 Asia Pacific Personalized Medicine Market Outlook, By Contract Research Organizations (2013-2022) ($MN)
Table 155 Asia Pacific Personalized Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
Table 156 Asia Pacific Personalized Medicine Market Outlook, By Molecular Diagnostic Laboratories and Testing facilities (2013-2022) ($MN)
Table 157 Asia Pacific Personalized Medicine Market Outlook, By Other End Users (2013-2022) ($MN)
Table 158 Asia Pacific Personalized Medicine Market Outlook, By Venture capitalists (2013-2022) ($MN)
Table 159 Asia Pacific Personalized Medicine Market Outlook, By Service providers (2013-2022) ($MN)
Table 160 Asia Pacific Personalized Medicine Market Outlook, By Partners (2013-2022) ($MN)
Table 161 Asia Pacific Personalized Medicine Market Outlook, By Application (2013-2022) ($MN)
Table 162 Asia Pacific Personalized Medicine Market Outlook, By Health Informatics (2013-2022) ($MN)
Table 163 Asia Pacific Personalized Medicine Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Table 164 Asia Pacific Personalized Medicine Market Outlook, By Clinical Research (2013-2022) ($MN)
Table 165 Asia Pacific Personalized Medicine Market Outlook, By Biomarker identification (2013-2022) ($MN)
Table 166 Asia Pacific Personalized Medicine Market Outlook, By Therapeutic area (2013-2022) ($MN)
Table 167 Asia Pacific Personalized Medicine Market Outlook, By Infectious Diseases (2013-2022) ($MN)
Table 168 Asia Pacific Personalized Medicine Market Outlook, By Hospital Acquired Infections (2013-2022) ($MN)
Table 169 Asia Pacific Personalized Medicine Market Outlook, By HIV (2013-2022) ($MN)
Table 170 Asia Pacific Personalized Medicine Market Outlook, By HCV (2013-2022) ($MN)
Table 171 Asia Pacific Personalized Medicine Market Outlook, By HBV (2013-2022) ($MN)
Table 172 Asia Pacific Personalized Medicine Market Outlook, By Coagulation Therapy (2013-2022) ($MN)
Table 173 Asia Pacific Personalized Medicine Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
Table 174 Asia Pacific Personalized Medicine Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)
Table 175 Asia Pacific Personalized Medicine Market Outlook, By CNS Disorders (2013-2022) ($MN)
Table 176 Asia Pacific Personalized Medicine Market Outlook, By Diabetes (2013-2022) ($MN)
Table 177 Asia Pacific Personalized Medicine Market Outlook, By Blood Transfusion Safety (2013-2022) ($MN)
Table 178 Asia Pacific Personalized Medicine Market Outlook, By Cancer Management (2013-2022) ($MN)
Table 179 Asia Pacific Personalized Medicine Market Outlook, By Blood Markers (2013-2022) ($MN)
Table 180 Asia Pacific Personalized Medicine Market Outlook, By Circulating Tumor Cells (2013-2022) ($MN)
Table 181 Asia Pacific Personalized Medicine Market Outlook, By Tissue-based Tests (2013-2022) ($MN)
Table 182 Asia Pacific Personalized Medicine Market Outlook, By Others (2013-2022) ($MN)
Table 183 Asia Pacific Personalized Medicine Market Outlook, By Product (2013-2022) ($MN)
Table 184 Asia Pacific Personalized Medicine Market Outlook, By Personalized Medicine Therapeutics (2013-2022) ($MN)
Table 185 Asia Pacific Personalized Medicine Market Outlook, By Genomic Medicine (2013-2022) ($MN)
Table 186 Asia Pacific Personalized Medicine Market Outlook, By Medical Devices (2013-2022) ($MN)
Table 187 Asia Pacific Personalized Medicine Market Outlook, By Pharmaceutical (2013-2022) ($MN)
Table 188 Asia Pacific Personalized Medicine Market Outlook, By Personalized Nutrition & Wellness (2013-2022) ($MN)
Table 189 Asia Pacific Personalized Medicine Market Outlook, By Alternative Medicine (2013-2022) ($MN)
Table 190 Asia Pacific Personalized Medicine Market Outlook, By Complementary Medicine (2013-2022) ($MN)
Table 191 Asia Pacific Personalized Medicine Market Outlook, By Retail Nutrition (2013-2022) ($MN)
Table 192 Asia Pacific Personalized Medicine Market Outlook, By Personalized Medical Care (2013-2022) ($MN)
Table 193 Asia Pacific Personalized Medicine Market Outlook, By Diseases Management (2013-2022) ($MN)
Table 194 Asia Pacific Personalized Medicine Market Outlook, By Healthcare Information Technology (2013-2022) ($MN)
Table 195 Asia Pacific Personalized Medicine Market Outlook, By Telemedicine (2013-2022) ($MN)
Table 196 Asia Pacific Personalized Medicine Market Outlook, By Personalized Medicine Diagnostics (2013-2022) ($MN)
Table 197 Asia Pacific Personalized Medicine Market Outlook, By Direct-to-consumer Diagnostics (2013-2022) ($MN)
Table 198 Asia Pacific Personalized Medicine Market Outlook, By Esoteric Lab Services (2013-2022) ($MN)
Table 199 Asia Pacific Personalized Medicine Market Outlook, By Esoteric Lab Tests (2013-2022) ($MN)
Table 200 Asia Pacific Personalized Medicine Market Outlook, By Genetic Testing (2013-2022) ($MN)
Table 201 RoW Personalized Medicine Market Outlook, By Country (2013-2022) ($MN)
Table 202 RoW Personalized Medicine Market Outlook, By Academic Institutes and Research Laboratories (2013-2022) ($MN)
Table 203 RoW Personalized Medicine Market Outlook, By Bio and health informatics companies (2013-2022) ($MN)
Table 204 RoW Personalized Medicine Market Outlook, By Contract Research Organizations (2013-2022) ($MN)
Table 205 RoW Personalized Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
Table 206 RoW Personalized Medicine Market Outlook, By Molecular Diagnostic Laboratories and Testing facilities (2013-2022) ($MN)
Table 207 RoW Personalized Medicine Market Outlook, By Other End Users (2013-2022) ($MN)
Table 208 RoW Personalized Medicine Market Outlook, By Venture capitalists (2013-2022) ($MN)
Table 209 RoW Personalized Medicine Market Outlook, By Service providers (2013-2022) ($MN)
Table 210 RoW Personalized Medicine Market Outlook, By Partners (2013-2022) ($MN)
Table 211 RoW Personalized Medicine Market Outlook, By Application (2013-2022) ($MN)
Table 212 RoW Personalized Medicine Market Outlook, By Health Informatics (2013-2022) ($MN)
Table 213 RoW Personalized Medicine Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Table 214 RoW Personalized Medicine Market Outlook, By Clinical Research (2013-2022) ($MN)
Table 215 RoW Personalized Medicine Market Outlook, By Biomarker identification (2013-2022) ($MN)
Table 216 RoW Personalized Medicine Market Outlook, By Therapeutic area (2013-2022) ($MN)
Table 217 RoW Personalized Medicine Market Outlook, By Infectious Diseases (2013-2022) ($MN)
Table 218 RoW Personalized Medicine Market Outlook, By Hospital Acquired Infections (2013-2022) ($MN)
Table 219 RoW Personalized Medicine Market Outlook, By HIV (2013-2022) ($MN)
Table 220 RoW Personalized Medicine Market Outlook, By HCV (2013-2022) ($MN)
Table 221 RoW Personalized Medicine Market Outlook, By HBV (2013-2022) ($MN)
Table 222 RoW Personalized Medicine Market Outlook, By Coagulation Therapy (2013-2022) ($MN)
Table 223 RoW Personalized Medicine Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
Table 224 RoW Personalized Medicine Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)
Table 225 RoW Personalized Medicine Market Outlook, By CNS Disorders (2013-2022) ($MN)
Table 226 RoW Personalized Medicine Market Outlook, By Diabetes (2013-2022) ($MN)
Table 227 RoW Personalized Medicine Market Outlook, By Blood Transfusion Safety (2013-2022) ($MN)
Table 228 RoW Personalized Medicine Market Outlook, By Cancer Management (2013-2022) ($MN)
Table 229 RoW Personalized Medicine Market Outlook, By Blood Markers (2013-2022) ($MN)
Table 230 RoW Personalized Medicine Market Outlook, By Circulating Tumor Cells (2013-2022) ($MN)
Table 231 RoW Personalized Medicine Market Outlook, By Tissue-based Tests (2013-2022) ($MN)
Table 232 RoW Personalized Medicine Market Outlook, By Others (2013-2022) ($MN)
Table 233 RoW Personalized Medicine Market Outlook, By Product (2013-2022) ($MN)
Table 234 RoW Personalized Medicine Market Outlook, By Personalized Medicine Therapeutics (2013-2022) ($MN)
Table 235 RoW Personalized Medicine Market Outlook, By Genomic Medicine (2013-2022) ($MN)
Table 236 RoW Personalized Medicine Market Outlook, By Medical Devices (2013-2022) ($MN)
Table 237 RoW Personalized Medicine Market Outlook, By Pharmaceutical (2013-2022) ($MN)
Table 238 RoW Personalized Medicine Market Outlook, By Personalized Nutrition & Wellness (2013-2022) ($MN)
Table 239 RoW Personalized Medicine Market Outlook, By Alternative Medicine (2013-2022) ($MN)
Table 240 RoW Personalized Medicine Market Outlook, By Complementary Medicine (2013-2022) ($MN)
Table 241 RoW Personalized Medicine Market Outlook, By Retail Nutrition (2013-2022) ($MN)
Table 242 RoW Personalized Medicine Market Outlook, By Personalized Medical Care (2013-2022) ($MN)
Table 243 RoW Personalized Medicine Market Outlook, By Diseases Management (2013-2022) ($MN)
Table 244 RoW Personalized Medicine Market Outlook, By Healthcare Information Technology (2013-2022) ($MN)
Table 245 RoW Personalized Medicine Market Outlook, By Telemedicine (2013-2022) ($MN)
Table 246 RoW Personalized Medicine Market Outlook, By Personalized Medicine Diagnostics (2013-2022) ($MN)
Table 247 RoW Personalized Medicine Market Outlook, By Direct-to-consumer Diagnostics (2013-2022) ($MN)
Table 248 RoW Personalized Medicine Market Outlook, By Esoteric Lab Services (2013-2022) ($MN)
Table 249 RoW Personalized Medicine Market Outlook, By Esoteric Lab Tests (2013-2022) ($MN)
Table 250 RoW Personalized Medicine Market Outlook, By Genetic Testing (2013-2022) ($MN)
Table 1 Global Personalized Medicine Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Personalized Medicine Market Outlook, By Academic Institutes and Research Laboratories (2013-2022) ($MN)
Table 3 Global Personalized Medicine Market Outlook, By Bio and health informatics companies (2013-2022) ($MN)
Table 4 Global Personalized Medicine Market Outlook, By Contract Research Organizations (2013-2022) ($MN)
Table 5 Global Personalized Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
Table 6 Global Personalized Medicine Market Outlook, By Molecular Diagnostic Laboratories and Testing facilities (2013-2022) ($MN)
Table 7 Global Personalized Medicine Market Outlook, By Other End Users (2013-2022) ($MN)
Table 8 Global Personalized Medicine Market Outlook, By Venture capitalists (2013-2022) ($MN)
Table 9 Global Personalized Medicine Market Outlook, By Service providers (2013-2022) ($MN)
Table 10 Global Personalized Medicine Market Outlook, By Partners (2013-2022) ($MN)
Table 11 Global Personalized Medicine Market Outlook, By Application (2013-2022) ($MN)
Table 12 Global Personalized Medicine Market Outlook, By Health Informatics (2013-2022) ($MN)
Table 13 Global Personalized Medicine Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Table 14 Global Personalized Medicine Market Outlook, By Clinical Research (2013-2022) ($MN)
Table 15 Global Personalized Medicine Market Outlook, By Biomarker identification (2013-2022) ($MN)
Table 16 Global Personalized Medicine Market Outlook, By Therapeutic area (2013-2022) ($MN)
Table 17 Global Personalized Medicine Market Outlook, By Infectious Diseases (2013-2022) ($MN)
Table 18 Global Personalized Medicine Market Outlook, By Hospital Acquired Infections (2013-2022) ($MN)
Table 19 Global Personalized Medicine Market Outlook, By HIV (2013-2022) ($MN)
Table 20 Global Personalized Medicine Market Outlook, By HCV (2013-2022) ($MN)
Table 21 Global Personalized Medicine Market Outlook, By HBV (2013-2022) ($MN)
Table 22 Global Personalized Medicine Market Outlook, By Coagulation Therapy (2013-2022) ($MN)
Table 23 Global Personalized Medicine Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
Table 24 Global Personalized Medicine Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)
Table 25 Global Personalized Medicine Market Outlook, By CNS Disorders (2013-2022) ($MN)
Table 26 Global Personalized Medicine Market Outlook, By Diabetes (2013-2022) ($MN)
Table 27 Global Personalized Medicine Market Outlook, By Blood Transfusion Safety (2013-2022) ($MN)
Table 28 Global Personalized Medicine Market Outlook, By Cancer Management (2013-2022) ($MN)
Table 29 Global Personalized Medicine Market Outlook, By Blood Markers (2013-2022) ($MN)
Table 30 Global Personalized Medicine Market Outlook, By Circulating Tumor Cells (2013-2022) ($MN)
Table 31 Global Personalized Medicine Market Outlook, By Tissue-based Tests (2013-2022) ($MN)
Table 32 Global Personalized Medicine Market Outlook, By Others (2013-2022) ($MN)
Table 33 Global Personalized Medicine Market Outlook, By Product (2013-2022) ($MN)
Table 34 Global Personalized Medicine Market Outlook, By Personalized Medicine Therapeutics (2013-2022) ($MN)
Table 35 Global Personalized Medicine Market Outlook, By Genomic Medicine (2013-2022) ($MN)
Table 36 Global Personalized Medicine Market Outlook, By Medical Devices (2013-2022) ($MN)
Table 37 Global Personalized Medicine Market Outlook, By Pharmaceutical (2013-2022) ($MN)
Table 38 Global Personalized Medicine Market Outlook, By Personalized Nutrition & Wellness (2013-2022) ($MN)
Table 39 Global Personalized Medicine Market Outlook, By Alternative Medicine (2013-2022) ($MN)
Table 40 Global Personalized Medicine Market Outlook, By Complementary Medicine (2013-2022) ($MN)
Table 41 Global Personalized Medicine Market Outlook, By Retail Nutrition (2013-2022) ($MN)
Table 42 Global Personalized Medicine Market Outlook, By Personalized Medical Care (2013-2022) ($MN)
Table 43 Global Personalized Medicine Market Outlook, By Diseases Management (2013-2022) ($MN)
Table 44 Global Personalized Medicine Market Outlook, By Healthcare Information Technology (2013-2022) ($MN)
Table 45 Global Personalized Medicine Market Outlook, By Telemedicine (2013-2022) ($MN)
Table 46 Global Personalized Medicine Market Outlook, By Personalized Medicine Diagnostics (2013-2022) ($MN)
Table 47 Global Personalized Medicine Market Outlook, By Direct-to-consumer Diagnostics (2013-2022) ($MN)
Table 48 Global Personalized Medicine Market Outlook, By Esoteric Lab Services (2013-2022) ($MN)
Table 49 Global Personalized Medicine Market Outlook, By Esoteric Lab Tests (2013-2022) ($MN)
Table 50 Global Personalized Medicine Market Outlook, By Genetic Testing (2013-2022) ($MN)
Table 51 North America Personalized Medicine Market Outlook, By Country (2013-2022) ($MN)
Table 52 North America Personalized Medicine Market Outlook, By Academic Institutes and Research Laboratories (2013-2022) ($MN)
Table 53 North America Personalized Medicine Market Outlook, By Bio and health informatics companies (2013-2022) ($MN)
Table 54 North America Personalized Medicine Market Outlook, By Contract Research Organizations (2013-2022) ($MN)
Table 55 North America Personalized Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
Table 56 North America Personalized Medicine Market Outlook, By Molecular Diagnostic Laboratories and Testing facilities (2013-2022) ($MN)
Table 57 North America Personalized Medicine Market Outlook, By Other End Users (2013-2022) ($MN)
Table 58 North America Personalized Medicine Market Outlook, By Venture capitalists (2013-2022) ($MN)
Table 59 North America Personalized Medicine Market Outlook, By Service providers (2013-2022) ($MN)
Table 60 North America Personalized Medicine Market Outlook, By Partners (2013-2022) ($MN)
Table 61 North America Personalized Medicine Market Outlook, By Application (2013-2022) ($MN)
Table 62 North America Personalized Medicine Market Outlook, By Health Informatics (2013-2022) ($MN)
Table 63 North America Personalized Medicine Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Table 64 North America Personalized Medicine Market Outlook, By Clinical Research (2013-2022) ($MN)
Table 65 North America Personalized Medicine Market Outlook, By Biomarker identification (2013-2022) ($MN)
Table 66 North America Personalized Medicine Market Outlook, By Therapeutic area (2013-2022) ($MN)
Table 67 North America Personalized Medicine Market Outlook, By Infectious Diseases (2013-2022) ($MN)
Table 68 North America Personalized Medicine Market Outlook, By Hospital Acquired Infections (2013-2022) ($MN)
Table 69 North America Personalized Medicine Market Outlook, By HIV (2013-2022) ($MN)
Table 70 North America Personalized Medicine Market Outlook, By HCV (2013-2022) ($MN)
Table 71 North America Personalized Medicine Market Outlook, By HBV (2013-2022) ($MN)
Table 72 North America Personalized Medicine Market Outlook, By Coagulation Therapy (2013-2022) ($MN)
Table 73 North America Personalized Medicine Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
Table 74 North America Personalized Medicine Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)
Table 75 North America Personalized Medicine Market Outlook, By CNS Disorders (2013-2022) ($MN)
Table 76 North America Personalized Medicine Market Outlook, By Diabetes (2013-2022) ($MN)
Table 77 North America Personalized Medicine Market Outlook, By Blood Transfusion Safety (2013-2022) ($MN)
Table 78 North America Personalized Medicine Market Outlook, By Cancer Management (2013-2022) ($MN)
Table 79 North America Personalized Medicine Market Outlook, By Blood Markers (2013-2022) ($MN)
Table 80 North America Personalized Medicine Market Outlook, By Circulating Tumor Cells (2013-2022) ($MN)
Table 81 North America Personalized Medicine Market Outlook, By Tissue-based Tests (2013-2022) ($MN)
Table 82 North America Personalized Medicine Market Outlook, By Others (2013-2022) ($MN)
Table 83 North America Personalized Medicine Market Outlook, By Product (2013-2022) ($MN)
Table 84 North America Personalized Medicine Market Outlook, By Personalized Medicine Therapeutics (2013-2022) ($MN)
Table 85 North America Personalized Medicine Market Outlook, By Genomic Medicine (2013-2022) ($MN)
Table 86 North America Personalized Medicine Market Outlook, By Medical Devices (2013-2022) ($MN)
Table 87 North America Personalized Medicine Market Outlook, By Pharmaceutical (2013-2022) ($MN)
Table 88 North America Personalized Medicine Market Outlook, By Personalized Nutrition & Wellness (2013-2022) ($MN)
Table 89 North America Personalized Medicine Market Outlook, By Alternative Medicine (2013-2022) ($MN)
Table 90 North America Personalized Medicine Market Outlook, By Complementary Medicine (2013-2022) ($MN)
Table 91 North America Personalized Medicine Market Outlook, By Retail Nutrition (2013-2022) ($MN)
Table 92 North America Personalized Medicine Market Outlook, By Personalized Medical Care (2013-2022) ($MN)
Table 93 North America Personalized Medicine Market Outlook, By Diseases Management (2013-2022) ($MN)
Table 94 North America Personalized Medicine Market Outlook, By Healthcare Information Technology (2013-2022) ($MN)
Table 95 North America Personalized Medicine Market Outlook, By Telemedicine (2013-2022) ($MN)
Table 96 North America Personalized Medicine Market Outlook, By Personalized Medicine Diagnostics (2013-2022) ($MN)
Table 97 North America Personalized Medicine Market Outlook, By Direct-to-consumer Diagnostics (2013-2022) ($MN)
Table 98 North America Personalized Medicine Market Outlook, By Esoteric Lab Services (2013-2022) ($MN)
Table 99 North America Personalized Medicine Market Outlook, By Esoteric Lab Tests (2013-2022) ($MN)
Table 100 North America Personalized Medicine Market Outlook, By Genetic Testing (2013-2022) ($MN)
Table 101 Europe Personalized Medicine Market Outlook, By Country (2013-2022) ($MN)
Table 102 Europe Personalized Medicine Market Outlook, By Academic Institutes and Research Laboratories (2013-2022) ($MN)
Table 103 Europe Personalized Medicine Market Outlook, By Bio and health informatics companies (2013-2022) ($MN)
Table 104 Europe Personalized Medicine Market Outlook, By Contract Research Organizations (2013-2022) ($MN)
Table 105 Europe Personalized Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
Table 106 Europe Personalized Medicine Market Outlook, By Molecular Diagnostic Laboratories and Testing facilities (2013-2022) ($MN)
Table 107 Europe Personalized Medicine Market Outlook, By Other End Users (2013-2022) ($MN)
Table 108 Europe Personalized Medicine Market Outlook, By Venture capitalists (2013-2022) ($MN)
Table 109 Europe Personalized Medicine Market Outlook, By Service providers (2013-2022) ($MN)
Table 110 Europe Personalized Medicine Market Outlook, By Partners (2013-2022) ($MN)
Table 111 Europe Personalized Medicine Market Outlook, By Application (2013-2022) ($MN)
Table 112 Europe Personalized Medicine Market Outlook, By Health Informatics (2013-2022) ($MN)
Table 113 Europe Personalized Medicine Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Table 114 Europe Personalized Medicine Market Outlook, By Clinical Research (2013-2022) ($MN)
Table 115 Europe Personalized Medicine Market Outlook, By Biomarker identification (2013-2022) ($MN)
Table 116 Europe Personalized Medicine Market Outlook, By Therapeutic area (2013-2022) ($MN)
Table 117 Europe Personalized Medicine Market Outlook, By Infectious Diseases (2013-2022) ($MN)
Table 118 Europe Personalized Medicine Market Outlook, By Hospital Acquired Infections (2013-2022) ($MN)
Table 119 Europe Personalized Medicine Market Outlook, By HIV (2013-2022) ($MN)
Table 120 Europe Personalized Medicine Market Outlook, By HCV (2013-2022) ($MN)
Table 121 Europe Personalized Medicine Market Outlook, By HBV (2013-2022) ($MN)
Table 122 Europe Personalized Medicine Market Outlook, By Coagulation Therapy (2013-2022) ($MN)
Table 123 Europe Personalized Medicine Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
Table 124 Europe Personalized Medicine Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)
Table 125 Europe Personalized Medicine Market Outlook, By CNS Disorders (2013-2022) ($MN)
Table 126 Europe Personalized Medicine Market Outlook, By Diabetes (2013-2022) ($MN)
Table 127 Europe Personalized Medicine Market Outlook, By Blood Transfusion Safety (2013-2022) ($MN)
Table 128 Europe Personalized Medicine Market Outlook, By Cancer Management (2013-2022) ($MN)
Table 129 Europe Personalized Medicine Market Outlook, By Blood Markers (2013-2022) ($MN)
Table 130 Europe Personalized Medicine Market Outlook, By Circulating Tumor Cells (2013-2022) ($MN)
Table 131 Europe Personalized Medicine Market Outlook, By Tissue-based Tests (2013-2022) ($MN)
Table 132 Europe Personalized Medicine Market Outlook, By Others (2013-2022) ($MN)
Table 133 Europe Personalized Medicine Market Outlook, By Product (2013-2022) ($MN)
Table 134 Europe Personalized Medicine Market Outlook, By Personalized Medicine Therapeutics (2013-2022) ($MN)
Table 135 Europe Personalized Medicine Market Outlook, By Genomic Medicine (2013-2022) ($MN)
Table 136 Europe Personalized Medicine Market Outlook, By Medical Devices (2013-2022) ($MN)
Table 137 Europe Personalized Medicine Market Outlook, By Pharmaceutical (2013-2022) ($MN)
Table 138 Europe Personalized Medicine Market Outlook, By Personalized Nutrition & Wellness (2013-2022) ($MN)
Table 139 Europe Personalized Medicine Market Outlook, By Alternative Medicine (2013-2022) ($MN)
Table 140 Europe Personalized Medicine Market Outlook, By Complementary Medicine (2013-2022) ($MN)
Table 141 Europe Personalized Medicine Market Outlook, By Retail Nutrition (2013-2022) ($MN)
Table 142 Europe Personalized Medicine Market Outlook, By Personalized Medical Care (2013-2022) ($MN)
Table 143 Europe Personalized Medicine Market Outlook, By Diseases Management (2013-2022) ($MN)
Table 144 Europe Personalized Medicine Market Outlook, By Healthcare Information Technology (2013-2022) ($MN)
Table 145 Europe Personalized Medicine Market Outlook, By Telemedicine (2013-2022) ($MN)
Table 146 Europe Personalized Medicine Market Outlook, By Personalized Medicine Diagnostics (2013-2022) ($MN)
Table 147 Europe Personalized Medicine Market Outlook, By Direct-to-consumer Diagnostics (2013-2022) ($MN)
Table 148 Europe Personalized Medicine Market Outlook, By Esoteric Lab Services (2013-2022) ($MN)
Table 149 Europe Personalized Medicine Market Outlook, By Esoteric Lab Tests (2013-2022) ($MN)
Table 150 Europe Personalized Medicine Market Outlook, By Genetic Testing (2013-2022) ($MN)
Table 151 Asia Pacific Personalized Medicine Market Outlook, By Country (2013-2022) ($MN)
Table 152 Asia Pacific Personalized Medicine Market Outlook, By Academic Institutes and Research Laboratories (2013-2022) ($MN)
Table 153 Asia Pacific Personalized Medicine Market Outlook, By Bio and health informatics companies (2013-2022) ($MN)
Table 154 Asia Pacific Personalized Medicine Market Outlook, By Contract Research Organizations (2013-2022) ($MN)
Table 155 Asia Pacific Personalized Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
Table 156 Asia Pacific Personalized Medicine Market Outlook, By Molecular Diagnostic Laboratories and Testing facilities (2013-2022) ($MN)
Table 157 Asia Pacific Personalized Medicine Market Outlook, By Other End Users (2013-2022) ($MN)
Table 158 Asia Pacific Personalized Medicine Market Outlook, By Venture capitalists (2013-2022) ($MN)
Table 159 Asia Pacific Personalized Medicine Market Outlook, By Service providers (2013-2022) ($MN)
Table 160 Asia Pacific Personalized Medicine Market Outlook, By Partners (2013-2022) ($MN)
Table 161 Asia Pacific Personalized Medicine Market Outlook, By Application (2013-2022) ($MN)
Table 162 Asia Pacific Personalized Medicine Market Outlook, By Health Informatics (2013-2022) ($MN)
Table 163 Asia Pacific Personalized Medicine Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Table 164 Asia Pacific Personalized Medicine Market Outlook, By Clinical Research (2013-2022) ($MN)
Table 165 Asia Pacific Personalized Medicine Market Outlook, By Biomarker identification (2013-2022) ($MN)
Table 166 Asia Pacific Personalized Medicine Market Outlook, By Therapeutic area (2013-2022) ($MN)
Table 167 Asia Pacific Personalized Medicine Market Outlook, By Infectious Diseases (2013-2022) ($MN)
Table 168 Asia Pacific Personalized Medicine Market Outlook, By Hospital Acquired Infections (2013-2022) ($MN)
Table 169 Asia Pacific Personalized Medicine Market Outlook, By HIV (2013-2022) ($MN)
Table 170 Asia Pacific Personalized Medicine Market Outlook, By HCV (2013-2022) ($MN)
Table 171 Asia Pacific Personalized Medicine Market Outlook, By HBV (2013-2022) ($MN)
Table 172 Asia Pacific Personalized Medicine Market Outlook, By Coagulation Therapy (2013-2022) ($MN)
Table 173 Asia Pacific Personalized Medicine Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
Table 174 Asia Pacific Personalized Medicine Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)
Table 175 Asia Pacific Personalized Medicine Market Outlook, By CNS Disorders (2013-2022) ($MN)
Table 176 Asia Pacific Personalized Medicine Market Outlook, By Diabetes (2013-2022) ($MN)
Table 177 Asia Pacific Personalized Medicine Market Outlook, By Blood Transfusion Safety (2013-2022) ($MN)
Table 178 Asia Pacific Personalized Medicine Market Outlook, By Cancer Management (2013-2022) ($MN)
Table 179 Asia Pacific Personalized Medicine Market Outlook, By Blood Markers (2013-2022) ($MN)
Table 180 Asia Pacific Personalized Medicine Market Outlook, By Circulating Tumor Cells (2013-2022) ($MN)
Table 181 Asia Pacific Personalized Medicine Market Outlook, By Tissue-based Tests (2013-2022) ($MN)
Table 182 Asia Pacific Personalized Medicine Market Outlook, By Others (2013-2022) ($MN)
Table 183 Asia Pacific Personalized Medicine Market Outlook, By Product (2013-2022) ($MN)
Table 184 Asia Pacific Personalized Medicine Market Outlook, By Personalized Medicine Therapeutics (2013-2022) ($MN)
Table 185 Asia Pacific Personalized Medicine Market Outlook, By Genomic Medicine (2013-2022) ($MN)
Table 186 Asia Pacific Personalized Medicine Market Outlook, By Medical Devices (2013-2022) ($MN)
Table 187 Asia Pacific Personalized Medicine Market Outlook, By Pharmaceutical (2013-2022) ($MN)
Table 188 Asia Pacific Personalized Medicine Market Outlook, By Personalized Nutrition & Wellness (2013-2022) ($MN)
Table 189 Asia Pacific Personalized Medicine Market Outlook, By Alternative Medicine (2013-2022) ($MN)
Table 190 Asia Pacific Personalized Medicine Market Outlook, By Complementary Medicine (2013-2022) ($MN)
Table 191 Asia Pacific Personalized Medicine Market Outlook, By Retail Nutrition (2013-2022) ($MN)
Table 192 Asia Pacific Personalized Medicine Market Outlook, By Personalized Medical Care (2013-2022) ($MN)
Table 193 Asia Pacific Personalized Medicine Market Outlook, By Diseases Management (2013-2022) ($MN)
Table 194 Asia Pacific Personalized Medicine Market Outlook, By Healthcare Information Technology (2013-2022) ($MN)
Table 195 Asia Pacific Personalized Medicine Market Outlook, By Telemedicine (2013-2022) ($MN)
Table 196 Asia Pacific Personalized Medicine Market Outlook, By Personalized Medicine Diagnostics (2013-2022) ($MN)
Table 197 Asia Pacific Personalized Medicine Market Outlook, By Direct-to-consumer Diagnostics (2013-2022) ($MN)
Table 198 Asia Pacific Personalized Medicine Market Outlook, By Esoteric Lab Services (2013-2022) ($MN)
Table 199 Asia Pacific Personalized Medicine Market Outlook, By Esoteric Lab Tests (2013-2022) ($MN)
Table 200 Asia Pacific Personalized Medicine Market Outlook, By Genetic Testing (2013-2022) ($MN)
Table 201 RoW Personalized Medicine Market Outlook, By Country (2013-2022) ($MN)
Table 202 RoW Personalized Medicine Market Outlook, By Academic Institutes and Research Laboratories (2013-2022) ($MN)
Table 203 RoW Personalized Medicine Market Outlook, By Bio and health informatics companies (2013-2022) ($MN)
Table 204 RoW Personalized Medicine Market Outlook, By Contract Research Organizations (2013-2022) ($MN)
Table 205 RoW Personalized Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
Table 206 RoW Personalized Medicine Market Outlook, By Molecular Diagnostic Laboratories and Testing facilities (2013-2022) ($MN)
Table 207 RoW Personalized Medicine Market Outlook, By Other End Users (2013-2022) ($MN)
Table 208 RoW Personalized Medicine Market Outlook, By Venture capitalists (2013-2022) ($MN)
Table 209 RoW Personalized Medicine Market Outlook, By Service providers (2013-2022) ($MN)
Table 210 RoW Personalized Medicine Market Outlook, By Partners (2013-2022) ($MN)
Table 211 RoW Personalized Medicine Market Outlook, By Application (2013-2022) ($MN)
Table 212 RoW Personalized Medicine Market Outlook, By Health Informatics (2013-2022) ($MN)
Table 213 RoW Personalized Medicine Market Outlook, By Companion Diagnostics (2013-2022) ($MN)
Table 214 RoW Personalized Medicine Market Outlook, By Clinical Research (2013-2022) ($MN)
Table 215 RoW Personalized Medicine Market Outlook, By Biomarker identification (2013-2022) ($MN)
Table 216 RoW Personalized Medicine Market Outlook, By Therapeutic area (2013-2022) ($MN)
Table 217 RoW Personalized Medicine Market Outlook, By Infectious Diseases (2013-2022) ($MN)
Table 218 RoW Personalized Medicine Market Outlook, By Hospital Acquired Infections (2013-2022) ($MN)
Table 219 RoW Personalized Medicine Market Outlook, By HIV (2013-2022) ($MN)
Table 220 RoW Personalized Medicine Market Outlook, By HCV (2013-2022) ($MN)
Table 221 RoW Personalized Medicine Market Outlook, By HBV (2013-2022) ($MN)
Table 222 RoW Personalized Medicine Market Outlook, By Coagulation Therapy (2013-2022) ($MN)
Table 223 RoW Personalized Medicine Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
Table 224 RoW Personalized Medicine Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)
Table 225 RoW Personalized Medicine Market Outlook, By CNS Disorders (2013-2022) ($MN)
Table 226 RoW Personalized Medicine Market Outlook, By Diabetes (2013-2022) ($MN)
Table 227 RoW Personalized Medicine Market Outlook, By Blood Transfusion Safety (2013-2022) ($MN)
Table 228 RoW Personalized Medicine Market Outlook, By Cancer Management (2013-2022) ($MN)
Table 229 RoW Personalized Medicine Market Outlook, By Blood Markers (2013-2022) ($MN)
Table 230 RoW Personalized Medicine Market Outlook, By Circulating Tumor Cells (2013-2022) ($MN)
Table 231 RoW Personalized Medicine Market Outlook, By Tissue-based Tests (2013-2022) ($MN)
Table 232 RoW Personalized Medicine Market Outlook, By Others (2013-2022) ($MN)
Table 233 RoW Personalized Medicine Market Outlook, By Product (2013-2022) ($MN)
Table 234 RoW Personalized Medicine Market Outlook, By Personalized Medicine Therapeutics (2013-2022) ($MN)
Table 235 RoW Personalized Medicine Market Outlook, By Genomic Medicine (2013-2022) ($MN)
Table 236 RoW Personalized Medicine Market Outlook, By Medical Devices (2013-2022) ($MN)
Table 237 RoW Personalized Medicine Market Outlook, By Pharmaceutical (2013-2022) ($MN)
Table 238 RoW Personalized Medicine Market Outlook, By Personalized Nutrition & Wellness (2013-2022) ($MN)
Table 239 RoW Personalized Medicine Market Outlook, By Alternative Medicine (2013-2022) ($MN)
Table 240 RoW Personalized Medicine Market Outlook, By Complementary Medicine (2013-2022) ($MN)
Table 241 RoW Personalized Medicine Market Outlook, By Retail Nutrition (2013-2022) ($MN)
Table 242 RoW Personalized Medicine Market Outlook, By Personalized Medical Care (2013-2022) ($MN)
Table 243 RoW Personalized Medicine Market Outlook, By Diseases Management (2013-2022) ($MN)
Table 244 RoW Personalized Medicine Market Outlook, By Healthcare Information Technology (2013-2022) ($MN)
Table 245 RoW Personalized Medicine Market Outlook, By Telemedicine (2013-2022) ($MN)
Table 246 RoW Personalized Medicine Market Outlook, By Personalized Medicine Diagnostics (2013-2022) ($MN)
Table 247 RoW Personalized Medicine Market Outlook, By Direct-to-consumer Diagnostics (2013-2022) ($MN)
Table 248 RoW Personalized Medicine Market Outlook, By Esoteric Lab Services (2013-2022) ($MN)
Table 249 RoW Personalized Medicine Market Outlook, By Esoteric Lab Tests (2013-2022) ($MN)
Table 250 RoW Personalized Medicine Market Outlook, By Genetic Testing (2013-2022) ($MN)
